Weekly Breakthroughs — science, tech & markets, three times a week

This week’s episode

Nightly AD109 pill cuts apnea | 🧪 World Labs Atlas turns one | MIT maps 31 striatum neuron | 🤖 AI reads ECGs for heart | FDA clears PrecivityAD2 Alzheimer’s blood | 🧬 Nagoya electrolyte hits 16.3 mS/cm

Sep '26 – This week brings breakthroughs in how we detect disease and understand biology at scale. From blood tests that spot Alzheimer's biomarkers to AI systems reading ECGs faster than cardiologists, medicine.

Article stream

Selected articles, synthesized in order

ScienceDaily2 min read

Nightly AD109 pill cuts apnea events 44%

A once-nightly oral medication, AD109, reduced the apnea-hypoxia index by about 44 percent in a large phase 3 trial presented at the 2026 ATS International Conference, compared with 18 percent on placebo. More than 40 percent of patients improved enough to move into a less severe obstructive sleep apnea category. Eighteen percent achieved complete disease control.

Read source

SiliconANGLE2 min read

World Labs Atlas turns one still into 1440p worlds

World Labs, co-founded by Fei-Fei Li, released Atlas, an omni model that builds detailed simulated 3D environments from a single image with precise camera control. From that input it can generate up to a minute of 1440p video that keeps rigid geometric consistency and can be viewed from any angle.

Read source

MIT News2 min read

MIT maps 31 striatum neuron groups by gene expression

MIT researchers used single-cell RNA sequencing and other techniques to split striatum neurons into 31 subgroups by which genes they express. They also found why some of those neurons are more vulnerable to Huntington’s disease. The groups include neurons involved in addiction, depression, and schizophrenia.

Read source

The Guardian2 min read

AI reads ECGs for heart disease in two seconds

Doctors trained an AI on millions of patients to pull more from a routine ECG than the eye typically sees, and it spots heart disease in less than two seconds. In a US trial of 67,000 patients, the tool identified up to 81 percent of people with heart failure and up to 90 percent with heart valve disease. It cannot diagnose or rule out those conditions on its own.

Read source

St. Louis Jewish Light2 min read

FDA clears PrecivityAD2 Alzheimer’s blood test

A diagnostic blood test grown from work by Washington University neurologists David Holtzman and Randall Bateman, PrecivityAD2, has been cleared by the FDA for marketing. The test helps doctors tell whether Alzheimer’s-associated amyloid plaques are present in patients 40 and older who have cognitive symptoms. WashU Medicine says it detects those biomarkers with more than 90 percent accuracy.

Read source

Interesting Engineering2 min read

Nagoya electrolyte hits 16.3 mS/cm lithium conductivity

Researchers at Nagoya University in Japan found that a fluoride ion inside a solid electrolyte shifts slightly whenever a lithium ion moves to a vacant site, clearing a path and lowering the energy barrier. Using that mechanism, they raised the material’s lithium-ion conductivity to a record 16.3 millisiemens per centimeter.

Read source

Markets

Trending stocks and pre-market pulse

Current extended-hours prices plus the plain-English reason each ticker is moving.

Wed, Sep 2, 6:32 AM EDT

S&P 500 Futures$7,625.50regular · -0.23%

regular · prior market settlement · 6:22 AM EDT

Nasdaq 100 Futures$28,979regular · -0.50%

regular · prior market settlement · 6:22 AM EDT

Dow Futures$52,750regular · -0.15%

regular · prior market settlement · 6:22 AM EDT

Gold$4,357.60-0.88%regular · prior market settlement · 6:22 AM EDT

Bitcoin$76,549-1.95%regular · rolling 24 hours · 6:30 AM EDT

DELLpre marketpre market · previous regular close · 6:32 AM EDT

+8.96%

Dell Technologies shares surged following a fiscal second-quarter report that surpassed analyst expectations for both revenue and earnings, driven by record AI server orders and a significant increase in its full-year outlook. The community reaction is highly bullish, with many traders viewing the r

MDBpre marketpre market · previous regular close · 6:17 AM EDT

-13.68%

MongoDB shares dropped significantly after the company's recent earnings report, as investors expressed disappointment over flat Atlas growth rates for three consecutive quarters and a cautious third-quarter revenue guidance, which overshadowed a clean headline beat and full-year guidance raise. Mar

GTLBpre marketpre market · previous regular close · 6:17 AM EDT

+19.21%

GitLab shares are trending following a fiscal second-quarter earnings beat, where the company reported strong revenue growth and raised its full-year guidance amid rising customer demand for its AI-powered platform. While some traders debate the stock's valuation and long-term profitability, the com

04 — Internet: For You

What’s buzzing online right now

X · Hacker News · Tech press

Claude Fable 5.1 one-shots motion videos Daniel Ch posted a clip he says Claude Fable 5.1 generated in 19 minutes, with only two changes. The post is the demo, not a paper.

@chddaniel

Open original

Gemini takes an agentic pass at video Google AI Studio says Gemini can now decide what to watch, at what speed, and in which modality instead of ingesting video at a fixed frame rate. They claim that cuts costs by up to 66 percent and token use by up to 88 percent, live on the Gemini API and in AI Studio.

@GoogleAIStudio

Open original

Previous episodes

Recent briefings you may have missed

View all

Mon, Jul 20, 2026MonInfrastructure Leaps and Biological Breakthroughs Transform Medicine and Technology
Fri, Jun 26, 2026FriThe Precision Revolution: From Atoms to Genomes, Control Becomes the New Frontier
Wed, Jun 24, 2026WedFrom Lab to Life: AI and Materials Science Reshape Medicine, Energy, and Manufacturing
Mon, Jun 22, 2026MonAI Ambitions Meet Open Alternatives as Immune Breakthroughs Reshape Medicine
Wed, Jun 17, 2026WedSmarter AI, Sharper Diagnostics, and Signals from Markets and the Web
Mon, Jun 8, 2026MonAI labs sound a biosecurity alarm. A cheaper path to clean hydrogen. Tesla jumps as the Nasdaq leads.
Tue, Mar 31, 2026Tue🧠 Thought-to-Speech Revolution | 🎮 Brain-Controlled Gaming | 🧬 Anti-Aging Immune Boost
Archived
Fri, Aug 29, 2025Fri🏫 The AI Hogwarts | 💉 Drug Discovery
Archived
Wed, Aug 6, 2025Wed🔋 AI Battery Breakthrough | 🩸 Longevity Secrets | 💊 HIV | 🇨🇳 China's Drug Discovery Race | 🌐 DeepMind's Genie-3 | 🤖 OpenAI Opens Up
Archived
Tue, Jul 29, 2025Tue🦟 Mosquito-Killing Pills | ✈️ AI Flight Deals | 🧬 Stuttering Genetics | 🧠 Whole-Brain Organoids | ⚛️ Einstein Challenged | 🫖 Tea
Archived

Join curious readers

Stay ahead of the curve.
Three times a week.

High-signal breakthroughs in science, tech, and markets. Under 3 minutes. No noise, no politics — just the future arriving early.

Free forever · Unsubscribe anytime · Delivered by Resend

The 3-minute briefingscience, tech &markets.

Nightly AD109 pill cuts apnea | 🧪 World Labs Atlas turns one | MIT maps 31 striatum neuron | 🤖 AI reads ECGs for heart | FDA clears PrecivityAD2 Alzheimer’s blood | 🧬 Nagoya electrolyte hits 16.3 mS/cm

Selected articles, synthesized in order

Nightly AD109 pill cuts apnea events 44%

World Labs Atlas turns one still into 1440p worlds

MIT maps 31 striatum neuron groups by gene expression

AI reads ECGs for heart disease in two seconds

FDA clears PrecivityAD2 Alzheimer’s blood test

Nagoya electrolyte hits 16.3 mS/cm lithium conductivity

What’s buzzing online right now

Recent briefings you may have missed

Stay ahead of the curve.Three times a week.

The 3-minute briefing
science, tech &
markets.

Stay ahead of the curve.
Three times a week.